The Usher syndrome (USH) is the most common form of inherited deaf-blindness, accompanied by vestibular dysfunction. Due to the heterogeneous manifestation of the clinical symptoms, three USH types (USH1-3) and additional atypical forms are distinguished. USH1 and USH2 proteins have been shown to function together in multiprotein networks in photoreceptor cells and hair cells. Mutations in USH proteins are considered to disrupt distinct USH protein networks and finally lead to the development of USH. To get novel insights into the molecular pathomechanisms underlying USH, we further characterize the periciliary USH protein network in photoreceptor cells. We show the direct interaction between the scaffold protein SANS (USH1G) and the transmembrane adhesion protein ush2a and that both assemble into a ternary USH1/USH2 complex together with the PDZdomain protein whirlin (USH2D) via mutual interactions. Immunohistochemistry and proximity ligation assays demonstrate co-localization of complex partners and complex formation, respectively, in the periciliary region, the inner segment and at the synapses of rodent and human photoreceptor cells. Protein-protein interaction assays and co-expression of complex partners reveal that pathogenic mutations in USH1G severely affect formation of the SANS/ush2a/whirlin complex. Translational read-through drug treatment, targeting the c.728C > A (p.S243X) nonsense mutation, restored SANS scaffold function. We conclude that USH1 and USH2 proteins function together in higher order protein complexes. The maintenance of USH1/USH2 protein complexes depends on multiple USH1/USH2 protein interactions, which are disrupted by pathogenic mutations in USH1G protein SANS.
Introduction
The human Usher syndrome (USH) is a rare disease representing the most common form of combined hereditary deaf blindness by affecting the ciliated sensory cells of the inner ear and the retina (1, 2) . USH is a complex clinically and genetically heterogeneous disorder with mutations causing either profound congenital deafness, vestibular dysfunction and pre-pubertal onset of retinitis pigmentosa (RP) (USH type 1), moderate progressive hearing impairment and variable onset of RP (USH type 2) or progressive hearing loss combined with variable vestibular and retinal dysfunctions (USH type 3) (1, (3) (4) (5) . Mutations in 10 genes are associated with the three USH types, but can also be the cause of non-syndromic deafness and blindness or can lead to clinical forms of atypical USH (1, (6) (7) (8) (9) (10) (11) . USH genes encode for very diverse protein classes and families, including molecular motors, cell-cell adhesion molecules, transmembrane proteins and receptors, Ca 2þ -binding proteins and scaffold proteins (1, 2, 12) .
The identification of binary interactions between USH1 and USH2 proteins and the decipherment of the protein networks related to USH has strongly contributed to the understanding of the pathophysiology of the USH disease (2, 6) . In both, the inner ear hair cells and the retinal photoreceptor cells of the eye, USH proteins are central components of membrane adhesion complexes (2, 6, 13) . USH proteins are found at synaptic contacts in both sensory systems (2, 14) . In addition, USH protein complexes are essential for the formation and function of supramolecular complexes associated with inter-stereocilia links of developing and mature hair cells, namely the tip-links, transient lateral links and the ankle-links reviewed by (13) . In photoreceptor cells, fibers, homologous to the ankle-links, span between the membranes of the connecting cilium and the inner segment (15) . It is thought that the long extracellular domains of the USH2 transmembrane proteins ush2a and VLGR1 (very large G-protein coupled receptor, USH2C (OMIM 605472)) build the core of these fibers and that their cytoplasmic domains are anchored within the periciliary cytoplasm by binding to the PDZ (PSD95, ZO-1, disc large) domains of the USH scaffold protein whirlin (USH2D, OMIM 611383) (6, (15) (16) (17) . In addition, there is growing evidence that this periciliary membrane-membrane adhesion complex is connected to the intracellular transport of cargo from the periciliary region in the apical inner segment to the outer segment of photoreceptor cells (15, (18) (19) (20) . In this connection, the USH1G (OMIM 606943) protein SANS (scaffold protein containing ankyrin repeats and SAM domain) is a central molecule. SANS is not only a component of the periciliary adhesion complex but is also associated with microtubules and the cytoplasmic dynein transport carrier machinery and thereby may bridge both systems (15, 18, 19, 21) . We have previously shown that SANS directly binds to the PDZ1 and PDZ2 domains of whirlin via its C-terminal SAM (sterile alpha motif) and the PDZ binding motif (PBM) (15) .
To gain deeper insight into the periciliary USH1/USH2 protein network of photoreceptor cells, we tested whether SANS scaffolds additional periciliary complex partners. We show that SANS also interacts with the transmembrane protein ush2a (usherin; USH2A, OMIM 276901) and that both USH proteins can assemble with whirlin into a ternary protein complex by mutual interactions of all three complex partners. In situ proximity ligation assays (PLA) confirm these interactions indicating that they occur in the inner segment and periciliary region of photoreceptor cells. Furthermore, we show that pathogenic mutations in USH1G interfere with the USH1/USH2 protein complex assembly. Moreover, we provide a promising treatment option to restore protein scaffold function of SANS disrupted by a nonsense mutation.
Results

Identification of USH2A as novel interaction partner of SANS
The close proximity of SANS and ush2a within the periciliary USH protein complex (15, 18, 20) prompted us to test their binding ability. For this, we applied GST-pull down assays using ush2a_icd as bait. Bacterial expressed GST-ush2a_icd fusion protein or GST alone were immobilized at glutathione sepharose beads and incubated with FLAG-tagged SANS protein. Subsequent Western blot analysis of the recovered proteins with anti-FLAG antibodies showed that ush2a_icd was able to pull down SANS, whereas GST alone was not, indicating the direct binding of SANS to the ush2a isoform b C-terminus in vitro ( Fig. 1A and B) . To validate the interaction between SANS and ush2a in a eukaryotic cellular environment, we performed membrane targeting assays, transfecting HEK293T cells with MyrPalm-eCFP tagged SANS and/or HA-ush2a_icd (Fig. 1C) . In singly transfected cells, HA-ush2a_icd was found in the nucleus and additionally very faint in the cytoplasm (Fig. 1C-a) . As expected, the membrane anchoring MyrPalm-tagged eCFP or eCFP-SANS were targeted to the plasma membrane (Fig. 1C-b) . However, in co-transfected cells, MyrPalm-eCFP-SANS recruited HA-ush2a_icd to the plasma membrane (Fig. 1C-c) , while the MyrPalm-eCFP alone did not (Fig. 1C-d) .
To specify the interacting region within the intracellular domain of ush2a, we used GST-tagged deletion constructs of the intracellular domain of ush2a and assayed for co-precipitation with FLAG-tagged SANS ( Fig. 2A) . In contrast to the GST control, all three ush2a_icd constructs were recovered after anti-FLAG pull down. The quantification of recovered polypeptides revealed that in comparison to the entire intracellular domain of ush2a (ush2a_icd, 100%), only about 80% of ush2a's C-terminus lacking the PDZ-binding motif (PBM) (ush2a_DPBM) and about 40% of the short ush2a_Cterm were recovered (Fig. 2B) .
To pinpoint the interaction domain within the SANS molecule, we performed the reciprocal experiment with FLAGtagged ush2a_icd and different GST-tagged SANS domains, namely the N-terminus (Nterm), the central domain (CENT) and the SAM-PBM (Fig. 2C) . The pull downs revealed that the central domain of SANS is the essential domain for direct binding to the ush2a C-terminus ( Fig. 2C and D) . Taken together, these results indicate that the central domain of SANS directly binds to the C-terminal part of the intracellular tail of ush2a and that the PBM of ush2a is not essential for this interaction.
SANS and ush2a assemble with whirlin into an UHS1/ USH2 protein complex
It has been previously shown that SANS and ush2a interact with the scaffold protein whirlin (USH2D) via binding of their PBMs to the PDZ1 and PDZ2 of whirlin (15, 16) . By this, whirlin anchors the transmembrane protein ush2a in the cytoplasm and organizes the periciliary membrane complex of USH1 and UHS2 proteins (15) (16) (17) .
The binary interaction of SANS and ush2a identified above motivated us to prove whether SANS and ush2a assemble into a ternary protein complex with whirlin. For this, we performed co-immunoprecipitations (co-IPs) incubating immobilized full length SANS (SANS_FL) with and without the C-terminal PBM (SANSDPBM) either with the intracellular domain of ush2a or with whirlin (Fig. 3A) . As expected from our experiments above, in both co-IPs ush2a_icd was recovered, indicating that the PBM in SANS is not necessary for ush2a binding. In contrast, whirlin binding to SANS was strictly dependent on the presence of the SANS' PBM domain (Fig. 3A) , affirming our previous results (15) . By sequential addition of ush2a and whirlin to SANS_FL or SANSDPBM, we observed the following changes in precipitation of whirlin ( Fig. 3A and B) : First, adding ush2a to SANS_FL significantly increased the amount of co-precipitated whirlin about four-fold (4.22 6 0.77; r ¼ 0.004). Second, whirlin was also recovered by SANSDPBM, when ush2a was added (6.86 6 2.81; r ¼ 0.029). Surprisingly, in these precipitations we observed a slight increase in the amount of whirlin, interacting with the ush2a/SANSDPBM complex compared to the ush2a/SANS full length complex (r ¼ 0.269).
In conclusion, we suggest that ush2a_icd can serve as a linker by simultaneous interaction with SANS_CENT and whirlin_PDZ1/PDZ2 as illustrated in Figure 3C . Therefore, the mutual interactions of all three proteins are suitable to form a USH1/USH2 protein complex in vitro.
Localization of ush2a protein complexes in retinal photoreceptor cells
Previous studies have demonstrated a periciliary USH2 protein membrane complex (15, 22) . Nevertheless, the precise localization of USH1 proteins in vertebrate photoreceptor cells is still controversially discussed (15, 16, (23) (24) (25) (26) (27) (28) (29) .
Thus, we aimed to get detailed insights into the spatial distribution of the complex components SANS, ush2a and whirlin in the ciliary region. For this, we performed immunofluorescence triple labeling experiments in murine and human retinal sections using antibodies against SANS, ush2a, and whirlin and counterstained the sections with anti-centrin3, a molecular marker for the connecting cilium, the basal body and the adjacent centriole (30, 31) (Fig. 4A-D) . Overlay images of these triple labeling confirmed the co-localization of SANS with ush2a and whirlin, respectively, at the ciliary base of murine photoreceptor cells, namely at the basal body and the adjacent centriole. Ush2a and whirlin are additionally co-localized along the connecting cilium ( Fig. 4B and D) . We observed a very similar protein distribution in human photoreceptor cilia ( Fig. 4C and D) . These results are in line with published data, which indicate that ush2a, whirlin and SANS are most abundant in the apical inner segment of photoreceptor cells, facing the connecting cilium (15, 22, 23, 32 ).
Next, we tested whether the USH protein complexes can be demonstrated in retinal photoreceptor cells in situ. For this, we performed proximity ligation assays (PLAs) on cryosections through unfixed murine retinae. Using PLA, interactions between SANS/ush2a, ush2a/whirlin, and SANS/whirlin were detected by applying specific antibody pairs against the partner proteins and visualized by subsequent confocal microscopy ( Fig. 5A-D) . As control, we performed PLA reactions applied each primary antibody alone. In comparison to these controls, we detected significant PLA signals for the SANS/ush2a, whirlin/ ush2a and SANS/whirlin complexes in all layers of the photoreceptor cell, with the exception of the outer segment ( Fig. 5A  and B) .
We quantified the PLA signals by counting the number of signals per 100 mm 2 in the distinct compartments of retinal photoreceptor cells (Fig. 5C ). By this, we determined that $ 20% of the PLA signals for SANS/ush2a and whirlin/ush2a, respectively, and 42% of SANS/whirlin were present in the outer plexiform layer (synaptic compartment) and only between 11% and 15% of signals of all PLA combinations were found in the outer nuclear layer (nuclear compartment). In any case most of the PLA signals are localized in the inner segment and the ciliary region of photoreceptor cells, namely 60% of SANS/ush2a and whirlin/ush2a complexes and 40% of SANS/whirlin complexes, respectively. Compared to the ciliary region, SANS/ush2a signals were significantly enriched in the inner segment (r ¼ 0.02), forming track-like structures (Fig. 5C , arrow in D). Furthermore, all possible interactions of the SANS/ush2a/whirlin complex were also detected at the base of the connecting cilium (Fig. 5D*) which is in line with the published immunofluorescence data (16, 18) .
Cellular expression of pathogenic USH1G mutations
Next, we aimed to test whether pathogenic mutations in the USH1G gene alter the cellular localization and/or scaffold function of the SANS protein. We selected 6 USH1G mutations, namely the c.728C > A/p.S243X nonsense mutation and three frameshift mutations, causing distinct truncations in the SANS central domain (c.393dup/p.V132Gfs*3; c.780_781insGCAC/ p.Y261Afs*96; c.829_848del/p.S278Pfs*71) and two missense mutations (c.310A > G/p.M104V; c.1373A > T/p.D458V), one in the ankyrin repeats and one in the PBM domain ( Fig. 6A and B). These mutations were reported in patients either with USH1, atypical USH or non-syndromic hearing loss (7, 8, 33, 34) . For our study, we transfected human HEK293T cells with wild-type (wt) SANS or SANS mutants fused to a Strep-FLAG tag (SF-N) ( Fig. 6C and D) . Immunofluorescence double labeling for SF-N-SANS and the centrosomal marker pericentrin (PCNT2) or the nuclear speckle marker PRPF6, respectively, combined with nuclear DAPI staining revealed that wt SANS accumulates around the centrosome and localizes to PRPF6-positive nuclear speckles in the nucleus (Fig. 6C) . The observed centrosomal localization and nuclear accumulation of SANS confirm previous reports on endogenous and transiently expressed SANS in murine cells (15, 23) .
Immunofluorescence analyses revealed that all 'mutated' SANS proteins were expressed in HEK293T cells after transfection. For mutant M104V and D458V_SANS the protein distribution was similar to that of SANS wt (Fig. 6D ). In contrast, the other SANS mutant proteins, which lack the C-terminal SAM-PBM, were depleted from the centrosome yet the nuclear fraction was increased. V132Gfs3*_SANS was equally distributed in the cytosol and the nucleus, whereas S243X, Y261Afs*96 and S278Pfs*71_SANS mostly localized to the nucleus (Fig. 6D ).
SANS mutations interrupt SANS/ush2a and SANS/ whirlin interactions
Next, we validated the effects of SANS mutations on the protein-protein interaction between SANS and ush2a. For this, we performed GST-pull down analyses with recombinant GSTtagged intracellular domain of ush2a (ush2a_icd) and SF-Ntagged SANS wt and mutant proteins (Fig. 7A ). Western blot analysis of the GST-pull downs showed that the single amino acid exchanges in the SANS molecule introduced by the missense mutations p.M104V and p.D458V did not interfere with the binding to ush2a_icd. In contrast, we did not recover SANS protein in ush2a_icd GST-pull downs from SANS protein mutants carrying frameshift mutations (V132Gfs*3, Y261Afs*96, S278Pfs*71) or the nonsense mutation (S243X) indicating that these truncated proteins are not able to bind to ush2a_icd (Fig. 7A) .
To validate the impact of SANS mutations on the interaction between SANS and whirlin, we individually expressed HAwhirlin and SF-N-SANS wt and mutation constructs in HEK293T cells, combined the lysates and subsequently performed immunoprecipitations using anti-FLAG antibodies (Fig. 7B) . Again, the truncated SANS mutants (V132Gfs*3, S243X, Y261Afs*96, S278Pfs*71) lost the ability for protein interaction (Fig. 7B) . The amount of whirlin, precipitated by SANS_M104V was reduced, whereas the amount of SANS_D458V binding to whirlin was variable compared to wt (data not shown). To scrutinize this variability, we co-expressed HA-whirlin and FLAG-tagged SANS_D458V in HEK293T cells (Supplementary Material, Fig. S1 ). Unexpectedly, if co-expressed with SANS_D458V, the amount of whirlin expression seemed to be dramatically reduced (Supplementary Material, Fig. S1A ). Further analysis showed no correlation between the decrease of the recovered whirlin protein amount and the duration of its expression (Supplementary Material, Fig. S1B ). Western blot analysis of the detergent soluble and the insoluble protein fractions of the HEK cell lysates revealed an increase of whirlin in the detergent insoluble palate when co-expressed with SANS_D458V in comparison to wt-SANS, but no decrease in whirlin expression.
In conclusion, in vitro interactions between SANS/ush2a and SANS/whirlin are disrupted by nonsense and frameshift mutations, but not by missense mutations in the USH1G gene. In addition, our results pinpoint to a SANS/ush2a and SANS/whirlin interaction site in the C-terminal region of SANS_CENT, including aa 279-385 (CENTc).
SANS mutations change subcellular distribution of SANS mediated protein complexes in HEK293T cells
Next, we analyzed the impact of SANS mutations on the protein localization of HA-ush2a and HA-whirlin, respectively, which were co-expressed with SF-N-SANS wt/mutants in HEK293T cells. As shown before, single expressed HA-ush2a_icd shows a diffuse staining in the nucleus and a faint staining in the cytoplasm (Supplementary Material, Fig. S2A ) (16) . Co-expression of wildtype SF-N-SANS leads to an altered localization pattern of HAush2a_icd, which accumulates in SF-N-SANS positive speckles in the nucleus (Supplementary Material, Fig. S2C ). The same HAush2a_icd re-localization was also observed when co-expressed with full length mutated SANS (M104V, D458V), but not for the truncated SANS mutants (V132Gfs*3, S234X, Y261Afs*96, S278Pfs*71, S278Pfs*71). (Supplementary Material, Fig. S2C ). Single expressed HA-whirlin is mainly localized in the cytoplasm (Supplementary Material, Fig. S2B ). When co-expressed with wildtype SF-N-SANS, both proteins co-localize in multiple accumulations all over the cytoplasm (Supplementary Material, Fig.  S2D ). The same was true for full length SANS mutants (M104V, D458V), but not for the truncated SANS constructs (V132Gfs*3, S234X, Y261Afs*96, S278Pfs*71, S278Pfs*71). Taken together, full length SANS, wt or mutated by missense mutations, interact with ush2a_icd and whirlin, respectively, on a cellular level, whereas truncated SANS does not.
Different SANS domains are involved in the interaction with ush2a and whirlin. Nevertheless, in vitro interaction as well as co-transfection assays revealed a breakdown of the SANS/ush2a and the SANS/whirlin interaction, whenever SANS is truncated due to frameshift or nonsense mutation in the central domain. In contrast, SANS missense mutations are still capable to interact with ush2a and with whirlin.
Translational read-through of SANS_S243X restores the interaction of SANS with ush2a
In previous studies, translational read-through became a valuable therapy option for in-frame nonsense mutations (35) . Translational read-through inducing drugs (TRIDs) allow the translation machinery to suppress a nonsense codon, elongate the nascent peptide chain and consequently result in the synthesis of full-length protein. A well-known TRID is PTC124 (Ataluren or Translarna TM ). PTC124 is approved for use in Duchenne muscular dystrophy caused by nonsense mutations in the EU and is in phase III clinical trials for treatment of cystic fibrosis caused by nonsense mutations (CF, OMIM 219700; ClinicalTrials.gov Identifier: NCT02107859) (35) . PTC124 has an excellent retinal biocompatibility making it a putative therapeutic for retinal disorders (36, 37) . In the human pathogenic USH1G mutation p.S243X, the TCA codon of serine (S) is altered to the premature stop codon TAA (X) (Figs 6A and 8A). This TAA stop codon is positioned in the CENT domain of SANS, leading to a truncated peptide (S243X) lacking the C-terminal half of the central domain and the SAM-PBM. Here, we analyzed read-through of this premature termination codon exemplarily for the most abundantly expressed SANS. For this, HEK293T cells were transfected with cDNAs encoding the FLAG tagged SANS S243X. After adding gentamycin or PTC124 to the culture medium, a dose-dependent increase in SANS expression was observed by Western blot (bands at 65kDa), applying anti-FLAG antibodies ( Fig. 8A and B) . We normalized the recovered SANS to the house keeping gene tubulin. This quantification revealed a significant increase in SANS expression after the treatment with 1 mg/ml gentamycin (7.7-fold increase), 5 mg/ml PTC124 (1.6-fold increase) or 10 mg/ml PTC124 (2.6-fold increase). In contrast, very low SANS expression was detected in DMSO-treated control cells (Fig. 8B) , likely a result of spontaneous read-through as previously reported for other nonsense mutations (37) .
In the present study, we showed, that the nonsense mutation p.S243X disturbs the interaction of SANS and ush2a (Fig. 7A  and Supplementary Material, Fig. S2C ). During translational read-through full-length SANS is recovered. However, the introduced amino acid is not necessarily the one of the wild type protein and such an amino acid substitution may interfere with protein function (38, 39) . In order to confirm functional recovery after TRID treatment, we tested for the interaction of SANS with the ush2a_icd (Fig. 8C) . Our RFP-Trap experiments, using RFPush2a_icd as bait, recovered a strong band, representing fulllength SANS from gentamycin and 10 mg/ml PTC124-treated cells, however, no band was present when using extracts of p.S243X-transfected, DMSO-treated cells. This confirms the presence of SANS full-length as well as the restoration of SANS' capability to mediate protein-protein interactions via the CENT domain. In conclusion, our data demonstrate that translational read-through inducing drugs (TRIDs) are a feasible treatment option for the USH1G nonsense mutation p.S243X.
Interestingly, in the RFP-ush2a_icd Trap samples with recovered full-length SANS, the truncated S243X protein was additionally co-precipitated, whereas in the absence of full-length SANS (Trap with DMSO control treated cells) no truncated protein was detected. This indicates that the truncated SANS_S243X is able to bind to restore full length SANS, narrowing the previously identified homomerization domain (21) down to aa 128-243 of SANS (Fig. 8C) , which we further referred to as SANS CENTn. Furthermore, we demonstrated the ability of full length SANS to bind mRFP-ush2a_icd and SANS_S243X simultaneously. Thus, SANS' ability for mediating SANS/ush2a interaction and SANS homomerization simultaneously promotes the scaffolding function of SANS in USH1/USH2 protein networks.
Discussion
SANS, ush2a and whirlin form a ternary USH1/USH2 protein complex
The present study is the first to describe the ternary interaction of USH1 and USH2 proteins, namely SANS (USH1G), ush2a/ usherin and whirlin (USH2D), localized in retinal photoreceptor cells (Fig. 9) . We previously showed that the C terminal PBM of SANS is required for the interaction with whirli ns PDZ1 and PDZ2 domains (15) . Here, we demonstrate that the transmembrane protein ush2a binds to the central domain of SANS (CENT) via its cytoplasmic C-terminus in vitro and in vivo in cultured cells. Domain annotations (SMART) do not predict protein-protein interaction domains or motifs in SANS_CENT (http://smart.embl-heidelberg.de/; date last accessed January 2017). However, our experimental analyses revealed that SANS_CENT serves as target site for several SANS binding proteins, which might compete for binding. In yeast-2-hybrid screens of retinal cDNA libraries, we previously identified more than 30 putative binding partners of the SANS_CENT domain, of which only a few, e.g. myosin VIIa (USH1B) and myomegalin (phosphodiesterase 4D interacting protein, PDE4DIP) have been confirmed, so far (15, 18, 20, 21) .
Combining our data from interaction assays analyzing SANS deletion constructs and SANS mutants we can narrow down the ush2a binding domain to 107 aa of SANS_CENT. This site, (aa 279-385) covers 95% of the two highly conserved subdomains CEN1 (aa 295-369) and CEN2 (aa 369-390), which were previously identified as binding sites for the MyTH4-FERM domains of myosin VIIa (21, 40) . Our data also showed that the binding of ush2a does not interfere with the homomerization of SANS (Fig. 8C) , which we previously linked to the CENT of murine SANS (aa 128-385) (21) . Our data indicate the existence of at least two distinct and independent interaction sites along the SANS central domain, namely the C-terminal CENTc (aa 279-390) for binding of ush2a and myosin VIIa, and a N-terminal site (CENTn, aa 128-243) for homomerization (Fig. 9A) . Moreover, the expression analysis of SANS mutants also identifies the SANS region required for centrosomal targeting to aa 279-461 comprising the C-terminal CENTc and the SAM-PBM of SANS.
For SANS-ush2a interactions, the PDZ-binding motif (PBM) at the very end of the ush2a C-terminus is not essential, but slightly increases its affinity (Fig. 2B) . This might be due to the structural adjustment of the designated binding site in SANS_CENTc by the PBM. The interaction between SANS and ush2a copes without the PBM domains of SANS and ush2a, respectively. Therefore, the PBM domains at the C-terminus of both proteins should be available for binding to PDZ domain containing whirlin (USH2D), which has been reported previously to bind to ush2a and SANS, respectively (16, 25) . This is precisely what we found in the present study, demonstrating assembly of a SANS/ush2a/whirlin ternary complex in vitro ( Fig. 9A and B) . This USH1/2 complex is mediated via synchronous interactions of ush2a with whirlin and SANS, respectively: ush2a_PBM binds to whirlin_PDZ1/PDZ2 and ush2a_icdDPBM binds to SANS. In the light of recent published data on SANS_CENT mediated interactions, we hypothesize that through this complex, SANS is also able to bind both partners simultaneously. This hypothesis is supported by structural analyses of SANS/harmonin and of SANS/myosin VIIa interactions, which indicated that there is no competition between CENT and SAM-PBM mediated interactions, confirming the scaffold function of SANS (40) (41) (42) .
Impact of USH1G mutations on the scaffold function of USH1G/SANS protein
Although 15 pathogenic mutations (out of 36 unique sequence variants) in USH1G have been identified thus far, the molecular mechanisms by which these mutations affect cellular functions remain poorly understood (LOVD-USHbase/13.11.2016 (43) . For some USH genes, a genotype-phenotype correlation has been reported (44) (45) (46) . The severe phenotype associated with USH1 is commonly the result of nonsense, frameshift and splice site mutations, resulting in the truncation of USH1 proteins. In contrast, 'leaky' splice sites and selected missense mutations in USH1 genes cause non-syndromic deafness (nsDFN) (reviewed in (6) .
In the present study, we analyzed the cellular distribution and scaffold function of SANS molecules affected by 6 different pathogenic mutations in USH1G (Fig. 6A ). Nonsense and frameshift mutations in USH1G lead to the loss of the peri-centriolar localization of the truncated SANS in HEK293T cells and interrupt its interaction with the USH2 proteins ush2a and whirlin. Since the homozygous nonsense and frameshift mutations in USH1G cause deaf-blindness (33, 34) , the interaction of SANS with ush2a and whirlin appear to be important for the function of both, retinal photoreceptor cells and inner ear hair cells. In contrast, missense mutations do not significantly affect the spatial distribution of the SANS molecule nor its binding ability to the USH2 proteins ush2a and whirlin. Nevertheless, these missense mutations still cause deafness in affected individuals. Homozygosity of the missense mutation p.D458V causes deafness in combination with late onset of vision loss, classified as atypical USH (8) . This indicates that this particular USH1G missense mutation affects additional molecular attributes of SANS molecules which are essential for the function of inner ear hair cells as well as the maintenance of retinal photoreceptor cells. Indeed, in vitro studies have previously shown that the missense mutation p.D458V severely affected the binding of SANS to USH1C protein harmonin (42) .
A second missense mutation (p.M104V) leads to isolated deafness and is described as a heterozygous compound mutation together with the heterozygous frameshift mutation (p.Y261Afs*96) (7) . Impaired function of SANS_p.Y261Afs*96 mutant might be compensated by the compound heterozygous missense mutation p.M104V in photoreceptor cells, but not in hair cells. Molecular modelling of the substitution of methionine to valine in the third ankyrin repeat only slightly changes the surface of SANS but does not alter the ankyrin repeat structure (7). This may affect the interaction with proteins that are essential in only cochlear function, causing isolated deafness (7). However, there are no proteins known, so far, which interact with any of the ankyrin repeats of SANS.
Together, our data indicate that the missense mutations p.M104V and p.D458V in USH1G are hypomorphic alleles, coding for at least partly functional SANS proteins. The residual function of SANS_M104V may retain normal retinal function. In contrast, frameshift mutations and the nonsense mutation SANS_p.S243X lead to truncated SANS molecules which may represent a functional null allele, thereby causing the USH1 phenotype. Encouragingly, application of PTC124/Ataluren lead to translational read-through of the premature stop codon, introduced by the SANS p.S243X nonsense mutation. The successful restoration of full length SANS was effective, and thereby reconstituted the SANS/ush2a interaction. In conclusion, our data demonstrate that translational read-through inducing drugs (TRIDs) are a feasible treatment option for the USH1G nonsense mutation p.S243X. 
Spatial distribution and putative function of SANS/ USH2A/whirlin complexes in photoreceptor cells
Present PLAs reveal native interactions between pairs of all three components of the ternary SANS/ush2a/whirlin protein complex at the synapses, in the inner segment and in the ciliary region of retinal photoreceptor cells. To our knowledge, this is the first demonstration of native USH protein complexes in photoreceptor cells in situ. The large overlap of the PLA signal from all three binding pairs (SANS/ush2a, ush2a/whirlin and SANS/whirlin) strongly supports the presence of the ternary complex in these photoreceptor cell compartments. The spatial distribution of the ternary complex is consistent with previous immunolocalization of single components and co-staining of components by light and electron microscopy in photoreceptor cells of diverse vertebrate species (1, 12, 15, 16, 22, 23, 29) .
Although there is evidence for the presence of USH proteins in the pre-and/or post-synaptic terminals of the synapses between the photoreceptor cells and secondary retinal neurons little is known about their function at this location (1) . The presence of PLA signals at outer retinal synapses suggests that USH proteins function as complexes in the specialized ribbon synapses. Due to the interaction of whirlin with the Cav1.3 Ca 2þ channel protein, a potential role in synaptic calcium channel positioning and membrane fusion has been suggested (47). Interestingly, both proteins are co-localized not only at the synapses, but also in the ciliary region of photoreceptor cells (48) . We previously identified other ciliary proteins at synapses where they may be related to vesicular transport and exocytosis processes (49, 50) . As illustrated in Figure 9C , the ternary SANS/ush2a/whirlin complex is related to the vesicular transport of outer segment cargo from the Golgi apparatus through the inner segment to the base of the photoreceptor cilium. In the inner segment, the ternary USH protein complex is localized along microtubules, which serve as transport tracks for the cytoplasmic dynein motor complex towards the base of the photoreceptor cilium. The ternary complex may either be transported as cargo or may participate in cytoplasmic dynein-mediated transport as a regulatory unit. Both hypotheses are consistent with the localization of the ternary USH protein complex in the inner segment and the periciliary region of photoreceptor cells. The cargo hypothesis is supported by following two findings: first, SANS, ush2a and whirlin are present in a sub-complex of membrane vesicles (51) . Second, a more recent study indicates that the correct preassembly of USH protein complexes in the ER is essential for the release into the Golgi and their subsequent apical transport and delivery to the stereocilia of hair cells in zebrafish models (52) .
The second hypothesis is strongly supported by the close association of SANS with the intracellular transport module in photoreceptor cells (18) (19) (20) . We recently found that SANS is part of the cytoplasmic dynein-based transport complexes for the transport of opsin and other phototransduction molecules of the outer segment (19) . In addition, SANS also serves in the regulation of endocytotic processes at the ciliary pocket in the periciliary region of the photoreceptor cells, which is thought to be related to the release of cargo vesicle from the dynein transport complex (20) .
The periciliary compartment of the photoreceptor inner segment harbors the targeting sites for the intracellular transport (15, 20, 53) . At this site, the cargo of the arriving transport vesicles is transferred from the dynein-based transport to the intraflagellar transport module powered by a kinesin II motor for the outer segment delivery (2) . The present PLAs demonstrate a very specific localization of the ternary SANS/ush2a/whirlin complex at the ciliary base of photoreceptor cells (see discussion above) indicating a role in this cargo-reloading process. There is evidence, that SANS is coupled not only to the cytoplasmic dynein motor but also to kinesin II motors (19) which further supports the bridging between both motor systems. Dysfunction in this transfer machinery should lead to defects in primary ciliogenesis, which indeed were observed in SANS depleted cells (20) .
Since reliable data support both hypotheses, it is reasonable that SANS fulfills a dual function, scaffolding the USH protein complex for the intracellular transport through the inner segment and regulating the cargo transfer from the inner segmental transport machinery to the ciliary transport module (intraflagellar transport, IFT) at the base of the photoreceptor cilium. Defects in any of these transport modules would lead to ciliary dysfunction underlying the pathogenic processes leading to ciliopathies such as the USH disease.
Knowledge about protein function is a prerequisite for the development of well-founded therapeutic strategies. Here, we further characterized healthy and mutant USH1G protein SANS and provide novel mechanistic insight into the USH1/USH2 protein complex formation in photoreceptor cells in health and disease. Finally, we strengthen the potency of translational readthrough therapy as a therapeutic tool for the USH1 causing nonsense mutation in SANS.
Materials and Methods
Antibodies and dyes
Polyclonal SANS antibodies generated against a murine fragment (amino acids 1-46), raised in rabbit, and guinea pig anti-SANS_CENT (against human amino acid 339-384) and guinea pig anti-whirlin (long isoform) and rabbit anti-ush2a (cytoplasmic tail) antibodies were previously characterized (1, 15, 16, 20) . Centrin3 or centrin2 were used as ciliary markers, respectively (30, 54) . Commercially available antibodies were used as followed: anti-tubulin (DM1A) and anti-FLAG (SAB1404762) from Sigma-Aldrich (Hamburg, Germany); anti-HA antibodies from Roche Diagnostics (Mannheim, Germany), anti-RFP antibodies from ChromoTek (Planegg-Martinsried, Germany), anti-GST from GE Health-care (Munich, Germany). Secondary antibodies conjugated to Alexa488, Alexa568 or Alexa 647 were purchased from Molecular Probes (Life Technologies, Darmstadt, Germany) or from Rockland Inc. (Gilbertsville, PA, USA). Nuclear DNA was stained with DAPI (4',6-diamidino-2-phenylindole) (1 mg/ml) (Sigma -Aldrich).
DNA constructs and mutagenesis
cDNAs for expression of proteins were obtained by RT-PCR or from EST-clones and subcloned into the appropriate expression vectors as previously described (16, 21) . The numbers of the given amino acids are according to the following Genbank entries: SANS (human, NP_775748,), ush2a isoform b (human, NP_996816), whirlin (human, NP_056219). For GST-pull down, immunoprecipitation and membrane targeting assays full length SANS, ush2a and whirlin or following deletion constructs of SANS and ush2a were used: SANS Nterm (aa 2-126), CENT (125-388), SAM-PBM (aa 385-461) and DPBM (aa 2-457), ush2a icd (aa 5064-5202), icdDPBM (aa 5046-5197) and Cterm (aa 5170-5197). cDNA was subcloned into either pDest15 (GST; Invitrogen TM ) for bacterial expression or into pCMV-3xFLAG (Invitrogen TM ), pDest/SF-N-TAP (55), pCMV-HA (Invitrogen  TM ) for expression in HEK293T cells. pGEX-4T3 (GE Healthcare, Freiburg, Germany) was used for bacterial expression of GST alone. SANS mutations were introduced into pDONR-SANS by using the QuikChange Lightning Site-Directed Mutagenesis Kit according to the manufacturer's protocol (Agilent Technologies, Waldbronn, Germany). Primers were designed on Agilent homepage (http://www.genomics.agilent.com; date last accessed May 2014) and mutagenesis PCR was performed according to the manufacturer's instructions. pDONR-SANS mutation constructs (V132Gfs*3, S243X, Y261Afs*96, S278Pfs*71, M104V, D458V) were subcloned into pDest/SF-N-TAP for expression in HEK293T cells using the Gateway L/R clonase II enzyme mix (InvitrogenTM, Karlsruhe, Germany).
Cell culture
HEK293T (human embryonic kidney cells) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal calf serum (FCS). Cells were transfected with plasmids using Lipofectamine LTX and Plus Reagent (InvitrogenTM, Karlsruhe, Germany) or GeneJuiceV R Transfection Reagent (Merck KGaA, Darmstadt, Germany) according to the manufacturer's instructions. For translational read-through studies, TRIDs were applied to the cells 6 h after transfection. PTC124 (Absource Diagnostics GmbH, Munich, Germany), was dissolved in dimethyl sulphoxide (DMSO) (Sigma-Aldrich, Deisenhofen, Germany). Gentamicin was purchased from Sigma-Aldrich. As a control for PTC124, DMSO was used in equivalent amounts. Cells were harvested after 48 h of TRID treatment.
GST-pull down assays
Three times 3xFLAG-tagged (FLAG-) human ush2a, SANS full length or SF-N-tagged SANS wt or mutants were expressed in HEK293T cells. 24 h post-transfection, cells were washed with PBS and subsequently lysed on ice in Triton X-100 lysis buffer (50 mM Tris-HCL pH 7.5, 150 mM NaCl, and 0.5% Triton X-100) containing a protease inhibitor cocktail (PI mix) (Roche Diagnostics GmbH, Risch, Suisse). The cell supernatant was incubated 3 h at 4 C with equal amounts of beads preincubated either with bacterial expressed GST-fusion proteins or with GST. Beads were washed with lysis buffer and precipitated protein complexes were eluted with SDS sample buffer and subjected to SDS-PAGE and Western blot (described in (18)).
Immunoprecipitation assays
For co-IP 3xFLAG-SANS (further referred to as FLAG-SANS) and HA-whirlin were expressed in HEK293T cells and lysed in Triton X-100 lysis buffer containing PI-mix. For the subsequent lysis of the pellet fraction we used Triton X-100 lysis buffer containing PI-mix and 0.1% Sarcosyl NL. Co-IP was performed using ANTI-FLAG beads from Sigma-Aldrich according to manufacturer's protocol. Briefly, we got cell lysates using Triton X-100 lysis buffer containing PI-mix, and incubated 3xFLAG-SANS constructs for 2 h on 4 C. After three washing steps with lysis buffer, samples were incubated for 2 h at 4 C with bacterial expressed GSTush2a fusion proteins, followed by three washing steps. The samples were eluted with SDS-sample buffer and subjected to SDS-page and Western blot, using antibodies against the FLAG-, and GST-tag. For triple co-IP, FLAG-SANS full length or DPBM, HA-tagged whirlin (human, pcDNA3-HA-Dest vector, aa 2-907), all singly expressed in HEK293T cells, and bacterial expressed GST-ush2a were used. FLAG-SANS fusion proteins were immobilized on ANTI-FLAGV R beads as described. After washing, GST-ush2a and HA-whirlin are added stepwise each incubated for 2 h at 4 C, followed by three washing steps with lysis buffer each time.
Samples were eluted with SDS-sample buffer and subjected to SDS-PAGE and Western blot, using antibodies against FLAG-, HA-and GST-tag.
RFP-trap
RFP polypeptides were immobilized at 25 ml Trap agarose beads (ChromoTek, Planegg-Martinsried, Germany) each and used for co-precipitation assays according to the manufacturer's protocol. Briefly, cell lysates from co-transfected HEK293T cells (mRFP-tagged ush2a_icd and FLAG-SANS wt or S243X) were suspended in lysis buffer (10 mM Tris -Cl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40), spun and the supernatant was diluted to 500 ml in dilution buffer (10 mM Tris -Cl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA). Fifty microliters were separated as input (total cell lysate) and samples were added to pre-washed beads for 2 h at 4 C under constant shaking. After several washing steps, precipitated protein complexes were eluted with SDSsample buffer and subjected to SDS-PAGE and Western blot.
Membrane targeting assay
Human SANS was fused to the N-terminal membraneanchoring peptide and eCFP expressed by the MyrPalm-eCFP vector (plasmid 14867, Addgene, Cambridge, MA, USA). MyrPalm-eCFP-SANS was single-or co-transfected with HAush2a_icd. 24 h post-transfection, cells were subjected to immunocytochemistry (see also (20) ).
Immunocytochemistry
Cells were washed in PBS, fixed with methanol containing 0.05% EGTA and subsequently washed 3-times with PBS followed by blocking (1% non-fat dry milk in PBS) for at least 30 min before primary antibodies were incubated overnight at 4 C. After washing, samples were incubated with secondary antibodies and DAPI for 1 h at room temperature. After washing, cover slips were mounted in Mowiol (Roth, Karlsruhe, Germany).
Animals and tissue dissection
All experiments were conducted in accordance with the Association for Research in Vision and Ophthalmology Statement for the care and use of Animals in Research. C57BL/6J mice were maintained under a 12 h light -dark cycle, with food and water ad libitum. After sacrifice of the animals in CO2 and decapitation, subsequently appropriate tissues were dissected.
Immunohistochemistry
Eyes of mice were cryofixed in melting isopentane and cryosectioned as described elsewhere (56) . Cryosections were placed on poly-L-lysine-precoated coverslips, incubated with 0.01% Tween 20 PBS, covered with blocking solution (0.5% cold-water fish gelatin, 0.1% ovalbumin in PBS) and incubated for minimum 30 min followed by over-night incubation at 4 C with primary antibodies. Washed cryosections were incubated with secondary antibodies in blocking solution containing DAPI (Sigma) for 1 h at room temperature. After washing, sections were mounted in Mowiol (Roth).
Proximity ligation assay
In situ PLA was used to visualize protein -protein interactions in the retina (57) . PLA probes were purchased from Olink Bioscience (Uppsala, Sweden): Duolink PLA probe anti-rabbit PLUS, Duolink in situ probemaker MINUS and Duolink in situ Detection Reagent Red. PLAs were performed on the unfixed cryosections of the murine retina as described in Bauß et al. 2014 with minor modifications. Briefly, cryosections were incubated overnight at 4 C with primary anti-bodies, subsequently counterstained with anti-centrin2 for 2 h before fixation with 2% paraformaldehyde in PBS. PLA probes were added to the sections for overnight incubation at 4 C. Ligation was performed for 30 min at 37 C and amplified for 100 min. For quantification of PLA signals, we applied the open source software ImageJ (http://rsb.info.nih.gov/ij/; date last accessed September 2015) to define the different layers of photoreceptor cells for semiautomated counting of fluorescent particles, as described previously (20) . We used five different images of one representative experiment for quantification of absolute number of PLA signals per area in each region. To test the significance, the number of signals in the experiment were alluded to the controls.
Image processing
The specimen was analyzed on a Leica DM6000B microscope (Leica, Bensheim, Germany), images were processed with Leica imaging software and ImageJ/Fiji software (58, 59) . Images in Figures 4-6 were 3D deconvoluted with Leica imaging software (BlindDeblur Algorithm, one iteration step). The co-localization map in Figure 5 was gathered by applying the Colocalization tool of ImageJ.
Statistical analyses
To prove for significance of observed differences, the Student's t-test was performed (unpaired, two tailed, assuming equal variance). P-value of 0.05 and below was considered to be significant. ImageJ software was used for Western Blot and PLA quantification. The Pearson coefficient was calculated using the Coloc 2 plugin of ImageJ. Localization of SANS wt and mutants in HEK293T cells was quantified with Cell profiler software (BROAD institute, Cambridge, MA, USA). Briefly, DAPI staining was used to identify nuclei as primary objects, anti-aÀtubulin staining was used to identify cell bodies as secondary objects. The cytoplasm was defined as tertiary object, which results from the subtraction of the primary object (nuclei) from the secondary object (cell body). Integrated intensity of cytoplasmic and nuclear region were quantified from 9-10 images out of three independent experiments each (>500 transfected cells per SANS variant).
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